Sort
15,273 grants matching “antimicrobial resistance”
Macrophage mitochodrial reprogramming and innate immune memory
$424,961Edward R Sherwood · Vanderbilt University Medical Center · R01 · FY2024 · AI
Macrophage mitochodrial reprogramming and innate immune memory
$424,961Edward R Sherwood · Vanderbilt University Medical Center · R01 · FY2023 · AI
Macrophage mitochodrial reprogramming and innate immune memory
$424,922Edward R Sherwood · Vanderbilt University Medical Center · R01 · FY2021 · AI
Neutrophil-intrinsic role of SLC11A1/NRAMP1 in control of bacterial infection
$424,879Renee M. Tsolis · University Of California At Davis · R01 · FY2022 · AI
T-Cell response to CD1-restricted lipids in Tuberculosis
$424,813David Branch Moody · Brigham And Women'S Hospital · R01 · FY2007 · AI
Survival of Neisseria gonorrhoeae after primary human neutrophil challenge
$424,741Alison K Criss · University Of Virginia · R01 · FY2018 · AI
Biomaterials that Prevent Biofilm Colonization and Device-based Infections
$424,602James D. Bryers · University Of Washington · R01 · FY2010 · EB
Molecular Basis of Host Parasite Interaction
$424,590Denise M. Monack · Stanford University · T32 · FY2019 · AI
The Staphylococcus aureus response to nutrient zinc restriction during infection
$424,580Eric P Skaar · Vanderbilt University Medical Center · R01 · FY2020 · AI
The Staphylococcus aureus response to nutrient zinc restriction during infection
$424,580Eric P Skaar · Vanderbilt University Medical Center · R01 · FY2024 · AI
The Staphylococcus aureus response to nutrient zinc restriction during infection
$424,580Eric P Skaar · Vanderbilt University Medical Center · R01 · FY2023 · AI
The Staphylococcus aureus response to nutrient zinc restriction during infection
$424,580Eric P Skaar · Vanderbilt University Medical Center · R01 · FY2021 · AI
The Staphylococcus aureus response to nutrient zinc restriction during infection
$424,580Eric P Skaar · Vanderbilt University Medical Center · R01 · FY2022 · AI
BACTERIAL RIBONUCLEASE P INHIBITORS AS NOVEL ANTIBIOTICS
$424,463Cubist Pharmaceuticals, Inc. · R44 · FY2000 · AI
Rapid culture-free analysis of bloodstream pathogens for transforming sepsis care
$424,265Rohit N Karnik · Massachusetts Institute Of Technology · R21 · FY2025 · AI
Novel Electrochemical Bandage for Treatment of Wound Infections
$424,176Robin Patel · Mayo Clinic Rochester · R01 · FY2024 · AI
Gallium, a potential new therapeutic for CF airway infections
$424,124Pradeep Singh · University Of Washington · R01 · FY2010 · HL
Selective Modulation of Neutrophils in Critical Illness
$424,040Craig Thomas Lefort · Rhode Island Hospital · R35 · FY2023 · GM
Task A18: Antibacterial MICs of a Gram-Negative Targeted Compound Collection
$424,000Leonard Duncan · Jmi Laboratories · N01 · FY2021 · AI
Staphylococcal Methicillin Resistance Locus
$423,920Gordon L. Archer · Virginia Commonwealth University · R56 · FY2009 · AI
Virulence Regulation by the Mycobacterium tuberculosis Proteasome
$423,750Katerina Heran Darwin · New York University School Of Medicine · R01 · FY2017 · HL
PROTEASOME-DEPENDENT DEGRADATION IN MYCOBACTERIUM TUBERCULOSIS
$423,750Katerina Heran Darwin · New York University School Of Medicine · R01 · FY2017 · AI
Unravelling lipid trafficking for the bacterial outer membrane
$423,750Damian Charles Ekiert · New York University School Of Medicine · R35 · FY2022 · GM
PROTEASOME-DEPENDENT DEGRADATION IN MYCOBACTERIUM TUBERCULOSIS
$423,750Katerina Heran Darwin · New York University School Of Medicine · R01 · FY2018 · AI
PROTEASOME-DEPENDENT DEGRADATION IN MYCOBACTERIUM TUBERCULOSIS
$423,750Katerina Heran Darwin · New York University School Of Medicine · R01 · FY2019 · AI